Pricing
Are Prepaid GLP-1 Plans Worth It? Running the Real Numbers
The discount is real. So is the money at risk if your situation changes.
Prepaid multi-month compounded GLP-1 plans advertise the lowest per-month rates in the market — but they charge the entire term up front against refund terms most providers leave vague. This piece runs the actual numbers on when the discount justifies the commitment, using captured NexLife plan structures.
What you're really trading
A prepaid plan converts a monthly decision into a lump-sum commitment. In exchange for paying the whole term today, you get a per-month rate typically 10–15% below the month-to-month price. The discount is real. What you give up is flexibility and, potentially, money: if you stop early — side effects, a dose change, a life event — you may not recover the unused portion, depending on refund terms that are frequently unstated.
The trade, quantified
| Plan | Per month | Due today | Annual saving vs monthly | At risk if stopped at month 1 |
|---|---|---|---|---|
| Month-to-month | $165.00 | $165.00 | — | $0 |
| 3-month prepaid | $149.00 | $447.00 | ~$192 | up to $298 |
| 6-month prepaid | $147.00 | $882.00 | ~$216 | up to $735 |
| 12-month prepaid | $145.00 | $1,740.00 | ~$240 | up to $1,575 |
The saving is modest and flattens quickly: going from month-to-month to 12-month prepaid saves about $240 a year, but the "at-risk" column grows far faster than the saving. On the 12-month plan you save $240 but expose up to $1,575 if you stop after one month. The discount rewards certainty; the commitment punishes a change of plans.
When prepaying makes sense — and when it doesn't
Prepay when three things are true: you have tolerated the medication and are confident you'll continue the full term, the provider's written refund policy is fair (pro-rated or refundable on unshipped medication), and the upfront amount is one you can absorb without strain. Don't prepay when you're new to the medication and haven't confirmed tolerance, when the refund policy is silent or explicitly no-refund, or when the saving is small relative to the amount at risk — which, as the table shows, is usually the case.
The three numbers to get in writing first
Before any prepaid plan: the exact amount charged today, the refund policy for medication not yet shipped, and whether cancellation carries a notice period or fee. Run the plan through the commitment calculator to see the due-today and worst-case-stranded figures side by side. A prepaid plan without a clear refund policy is not a discount; it's an unsecured loan to the provider.
Frequently asked questions
How much do prepaid plans actually save?
Typically 10–15% off the month-to-month rate, which on captured plans works out to roughly $200–$250 a year. The saving is real but modest, and it shrinks as a fraction of the total the longer the term. Weigh it against the amount you'd forfeit if you stopped early, which is usually much larger.
What happens to my money if I stop mid-plan?
It depends entirely on the refund policy, which varies from full pro-rated refunds to strict no-refunds once medication ships. Many compounded-GLP-1 plans restrict refunds after the first shipment. Because this term is so consequential and so often undisclosed, getting it in writing before paying is the single most important step.
Is a prepaid "monthly equivalent" a monthly bill?
No. A "$145/month" annual plan is a $1,740 charge today divided by twelve for display — not a subscription you can cancel each month. Treating the equivalent as a monthly bill is the most expensive misunderstanding in this market. The commitment calculator exists to make the distinction visible.
Evidence status. Pricing figures are provider-reported or independently calculated as of 2026-07-20, not checkout-verified. Compounded medications are not FDA approved. This article is consumer education, not medical advice. See the methodology for how figures are gated and the public evidence ledger for per-figure sources. Found an error? Use the corrections route.
Independent & transparent
Independently operated by US Peptides Partners LLC. Rankings are editorial, computed from published pricing under the methodology, and are not for sale. Outbound provider links carry referral-tracking tags; no arrangement changes a ranking — if a provider out-scores the current leader on captured figures, the ranking changes.